Bone Marrow Disease News and Research

RSS
MD Anderson researchers report early success of novel menin-targeted therapies in leukemia

MD Anderson researchers report early success of novel menin-targeted therapies in leukemia

Benjamin L. Ebert receives Sjöberg Prize for breakthrough research on blood cancer

Benjamin L. Ebert receives Sjöberg Prize for breakthrough research on blood cancer

Novel antibody-drug conjugate shows 29% response rate in rare blood cancer

Novel antibody-drug conjugate shows 29% response rate in rare blood cancer

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

Bone marrow disease is stimulated by vitamin D and immune cells, reveals research

Bone marrow disease is stimulated by vitamin D and immune cells, reveals research

Protein CDK6 appears to be key factor in influencing development of MPN

Protein CDK6 appears to be key factor in influencing development of MPN

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera

Apellis Pharmaceuticals completes $33M private placement of Series C Preferred Stock

Apellis Pharmaceuticals completes $33M private placement of Series C Preferred Stock

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

Researchers discover that immune cells control blood stem cells in bone marrow

Researchers discover that immune cells control blood stem cells in bone marrow

Researchers find that 20% of women with ovarian cancer had inherited mutations in gene pathway

Researchers find that 20% of women with ovarian cancer had inherited mutations in gene pathway

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

FDA approves Bosulif to treat chronic myelogenous leukemia

FDA approves Bosulif to treat chronic myelogenous leukemia

FDA approves new supplies of drugs that are facing shortages

FDA approves new supplies of drugs that are facing shortages

Novartis' Gleevec receives FDA approval for use in patients with CD117-positive GIST

Novartis' Gleevec receives FDA approval for use in patients with CD117-positive GIST

Severe combined immunodeficiency treated successfully with gene therapy

Severe combined immunodeficiency treated successfully with gene therapy

Half-matched transplants widen donor pool for leukemia and lymphoma

Half-matched transplants widen donor pool for leukemia and lymphoma

Potential new approach for treating myelofibrosis

Potential new approach for treating myelofibrosis

New insights into cancer genome may lead to designer drugs for myeloma

New insights into cancer genome may lead to designer drugs for myeloma

First “saviour sibling” procedure successful

First “saviour sibling” procedure successful

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.